Peptide Science,
Simplified
Research-backed articles on peptide therapeutics, clinical findings, and compound profiles. Every claim cited. Every source verified. Built for practitioners and informed patients.
100%
Source-Cited Content
PubMed
Primary Source Database
Expert
Reviewed Before Publishing
Daily
Research Updates
Compound Profiles
View All →BPC-157 (Body Protection Compound-157)
Gastric Pentadecapeptide — Cytoprotective and Regenerative Peptide
BPC-157 is a synthetic 15-amino-acid gastric pentadecapeptide with a molecular weight of 1,419.53 Da, derived from a protective protein in human gastric juice. Over 100 published preclinical studies have investigated its effects on tissue repair, angiogenesis, and gastrointestinal protection through VEGFR2 and nitric oxide signaling pathways.
CJC-1295
Growth Hormone-Releasing Hormone Analog — Modified GRF(1-29)
CJC-1295 is a synthetic 29-amino-acid GHRH analog available in two forms: with and without Drug Affinity Complex (DAC), yielding half-lives of 6-8 days and 30 minutes to 2 hours, respectively. Clinical research has demonstrated dose-dependent increases in growth hormone (2-10x) and IGF-1 (1.5-3x) in healthy adults.
GHK-Cu (Copper Peptide)
Naturally Occurring Tripeptide-Copper Complex
GHK-Cu is a naturally occurring tripeptide-copper complex that modulates expression of over 4,000 human genes. Research using the Broad Institute Connectivity Map has documented effects on DNA repair, collagen synthesis, and anti-inflammatory pathways, with established use in topical wound healing and dermatology.
Latest Articles
View All →BPC-157 and Gut Health: What the Research Says
BPC-157, a 15-amino-acid peptide derived from human gastric juice, has been studied extensively for its potential cytoprotective and healing effects on the gastrointestinal tract. Research spanning three decades suggests it may support gastric ulcer healing, intestinal repair, and inflammatory bowel conditions through multiple biological pathways.
Collagen Peptides and Joint Health: What the Clinical Evidence Shows
Clinical trials suggest hydrolyzed collagen peptides may reduce osteoarthritis pain and support cartilage maintenance. A meta-analysis of 507 patients and multiple RCTs reveal promising results, though researchers emphasize the need for larger, longer-term studies.
The Science of GHK-Cu: Copper Peptide Research in Wound Healing and Anti-Aging
GHK-Cu is a naturally occurring copper-binding tripeptide that declines with age and has been studied for over 50 years for its effects on wound healing, collagen stimulation, and skin regeneration. Clinical trials have demonstrated accelerated wound closure in diabetic ulcers, while gene expression studies reveal the peptide may influence over 4,000 human genes involved in tissue repair and anti-aging pathways.
Research
View All →Antimicrobial Peptides: Next-Generation Alternatives to Conventional Antibiotics in the Era of Drug Resistance
Antimicrobial peptides (AMPs) are emerging as promising alternatives to conventional antibiotics in the fight against drug-resistant infections. These naturally occurring molecules employ multiple mechanisms including membrane disruption, intracellular targeting, and immunomodulation, making bacterial resistance development slower and more costly than with traditional antibiotics.
BPC-157 and Tendon-Ligament Healing: Preclinical Evidence for Accelerated Musculoskeletal Repair
Preclinical rat studies demonstrate that BPC-157, a gastric pentadecapeptide, accelerates Achilles tendon and medial collateral ligament healing through growth hormone receptor upregulation and angiogenesis modulation. The peptide shows efficacy via oral, injectable, and topical administration routes.
Collagen Peptide Supplementation: Systematic Reviews and Meta-Analyses on Skin, Joint, and Bone Outcomes
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that oral collagen peptide supplementation significantly improves skin hydration and elasticity, reduces joint pain, and increases bone mineral density. The evidence is strongest for skin outcomes across 26 pooled RCTs.
Latest News
View All →AI-Driven Peptide Drug Discovery Is Reshaping Pharmaceutical Development
Artificial intelligence is transforming peptide drug discovery, with billion-dollar pharma deals, generative AI design tools, and over 78 percent of recent peptide-drug conjugates using AI-optimized components. The technology stack is compressing development timelines from years to months.
Compounding Pharmacy Regulatory Landscape Tightens as FDA and Congress Act on GLP-1 Enforcement
The FDA has cracked down on compounded GLP-1 agonists following shortage resolutions, while Congress has introduced the SAFE Drugs Act proposing sweeping new restrictions on 503A and 503B compounding pharmacies. State regulators are following suit with tighter oversight.
FDA Peptide Reclassification Opens Door for Compounding Pharmacies in 2026
The FDA's reclassification of 12 peptides from Category 2 restrictions in April 2026 has reopened the door for compounding pharmacies. With the Pharmacy Compounding Advisory Committee set to review BPC-157, TB-500, and other peptides in July, practitioners are watching closely as the regulatory landscape shifts.
Stay Current with Peptide Science
New research summaries, compound profiles, and industry news published regularly. All content is evidence-based and source-cited.